Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA clears laser therapy for vitiligo:

This article was originally published in Clinica

Executive Summary

The US FDA has cleared for sale what it claimed is the first excimer laser system for treating vitiligo, a skin disease that causes a loss of pigmentation. The XTRAC laser device, made by Photomedex of Radnor, Pennsylvania, eradicates the white spots caused by vitiligo, restoring the skin to the same condition as before the onset of the disease. The company says that until now, there has been no known cure or effective treatment for the disease, which is known to affect around two to four million people in the US.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT070229

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel